您当前的位置:华夏生活网行业资讯正文

喜大普奔银屑病患者渴盼的好药进入国家医保了

2019-12-18 11:17:03  阅读:8581+ 作者:责任编辑NO。杜一帆0322

参考文献:

1.http:///art/2019/11/28/art_37_2050.html

2.Chiricozzi A , et al. Journal of the European Academy of Dermatology and Venereology, 2016.

3.Tracey D, et al. Pharmacol Ther. 2008;117(2):244-279.

4.Lapadula G, et al. Int J Immunopathol Pharmacol. 2014;27(1 Suppl):33-48

5. Burmester, G.R., Gordon, K.B., Rosenbaum, J.T. et al. Adv Ther (2019).

6.Burmester, G.R., Gordon, K.B., Rosenbaum, J.T. et al. Adv Ther (2019). Table 2

7. Menter A, et al.J Am Acad Dermatol 2008;58:826-50.

8.Smith CH, et al. Br J Dermatol. 2017.17. doi: 10.1111/bjd.15665.

9. Hsu S, et al.Arch Dermatol. 2012;148(1):95-102

“如果发现本网站发布的资讯影响到您的版权,可以联系本站!同时欢迎来本站投稿!